Welcome to our dedicated page for Black Bird Biotech news (Ticker: BBBT), a resource for investors and traders seeking the latest updates and insights on Black Bird Biotech stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Black Bird Biotech's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Black Bird Biotech's position in the market.
Black Bird Biotech, Inc. (OTC PINK:BBBT) announced preliminary findings from a four-month study conducted by Botanical Research in Motion, Inc. on its biopesticide, MiteXstream. The results confirmed its effectiveness against spider mites, particularly when applied every 2 to 3 days. Following these findings, BBBT aims to apply for clearance to sell MiteXstream in California, expanding its market presence beyond 31 states. The formal efficacy report is expected later this month, which will further bolster sales potential.
Black Bird Biotech, Inc. (OTC PINK: BBBT) has appointed Rich Forbis as National Sales General Manager to enhance the sales and marketing of its biopesticide MiteXstream. Forbis, with over 30 years of experience, aims to leverage his business contacts to drive growth, particularly as the cannabis market expands. MiteXstream is an EPA-certified product that targets harmful pests without toxic residues, making it suitable for cannabis cultivation. The product is currently available in several states, with applications pending in others.
Black Bird Biotech (OTC PINK:BBBT) recently announced that its MiteXstreamTM biopesticide has shown effectiveness in repelling pests like grasshoppers and potato bugs during in-field tests. With existing EPA certification, this could provide the product a competitive edge. The company highlights potential for MiteXstreamTM to replace toxic insecticides if third-party testing confirms its repellent properties. The product is currently available in several states, with plans to expand further.
Black Bird Biotech (OTC PINK:BBBT) has launched an online store for its biopesticide, MiteXstream, to enable direct sales to commercial and home users. This initiative is aimed at capitalizing on the growing cannabis market, projected to reach $45 billion by 2025. The redesigned website facilitates traffic from BBBT's marketing efforts targeting large agricultural customers, including coffee farms and vineyards. MiteXstream is currently available in several states, with pending applications nationwide, excluding California. The biopesticide is designed for safe use without residual pesticide concerns.
Black Bird Biotech, Inc. (OTC PINK: BBBT) has successfully repaid approximately $225,000 in convertible notes, enhancing shareholder protection by eliminating potential market overhang from below-market conversions. President Fabian Deneault emphasized the company’s goal to be debt-free by the end of 2021, indicating a strategic move towards financial stability. Black Bird Biotech specializes in MiteXstream biopesticide, aimed at safeguarding crops from pests with a non-toxic alternative.
Black Bird Biotech (OTC PINK:BBBT) announced that an international agri-chemical distributor in the Middle East will begin field testing its plant-based MiteXstream biopesticide on various crops in October 2021. This testing responds to rising mite populations and the need for effective pest control solutions that do not lead to resistance. MiteXstream offers potential annual savings of billions in crop losses and has shown high efficacy without raising resistance. The product is also effective against molds, including powdery mildew, highlighting its extensive agricultural applications.
Black Bird Biotech (OTC PINK:BBBT) announced its first sales of the MiteXstream biopesticide and seeks approval in all remaining U.S. states and D.C. for its use in the growing cannabis industry, projected to reach $45 billion by 2025. Currently, MiteXstream is approved in seven states and has pending applications in eight others. The company is also pursuing international sales channels in regions like China and Central America. MiteXstream is noted for its effectiveness against pests without being toxic, allowing use up to harvest.
Black Bird Biotech, Inc. (OTC PINK:BBBT) announced its first sales of the plant-based biopesticide MiteXstreamTM, aimed at enhancing crop protection in the burgeoning cannabis industry, expected to reach $45 billion by 2025. The company is ramping up sales and marketing efforts and is exploring international channels, particularly in Asia and Central America. Feedback from initial customer Dylan Matteson highlights MiteXstreamTM's effectiveness against pests while remaining safe for use up to harvest. CEO Fabian Deneault anticipates significant growth opportunities for the product.
Black Bird Biotech, Inc. (OTC PINK: BBBT) announced its plan to seek EPA approval for the Ready-to-Use formulation of its biopesticide, MiteXstream™, targeting the home gardening market.
CEO Fabian Deneault expressed enthusiasm about providing a user-friendly solution for gardeners facing pest issues. The application to the EPA is expected to be filed in August, with certification anticipated in the latter half of Q2 2022. MiteXstream™ is noted for its effectiveness against spider mites and molds without toxic residue concerns.
Black Bird Biotech, Inc. (OTC PINK:BBBT) announces that its biopesticide, MiteXstream, will undergo field testing in Israel starting this summer, targeting mite-infested eggplant and cucumber crops. This collaboration with an international agri-chemical company follows MiteXstream's recent EPA registration and aims to validate its effectiveness as a low-cost, plant-based solution. The testing is expected to conclude by early October, underscoring the product's potential impact on global agricultural markets.
FAQ
What is the current stock price of Black Bird Biotech (BBBT)?
What is the market cap of Black Bird Biotech (BBBT)?
